Connection

Joseph John to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Joseph John has written about Clinical Trials, Phase II as Topic.
Joseph John
Connection Strength
0.065
Clinical Trials, Phase II as Topic
  1. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.